New Mexico Woman Seeks $75,000 in Lipitor Diabetes Lawsuit

Lopez was prescribed Lipitor between 1992 and 1993, and was diagnosed with type-2 diabetes in October 2012. At no point in time did Pfizer warn the patient or her physician about these possible side effects, the Lipitor lawsuit says.

Lopez alleges that Pfizer concealed information about Lipitor causing type-2 diabetes, and is therefore negligent in its conduct of action. Lopez is suing Pfizer for negligence, alleging the company manufactured, sold, distributed and marketed a dangerous product. She is also bringing charges of concealing information, misrepresenting a product, and false advertising.

Lopez is seeking over $75,000 in damages through her Lipitor lawsuit.

Overview of Lipitor Diabetes Complications

A study published on May 23, 2013, in the British Medical Journal has caused Canada to follow America’s lead concerning statin drugs possibly causing type-2 diabetes in patients. Due to this study, Health Canada recently launched an investigation into statin drugs and their association with type-2 diabetes. 

In this study, Canadian researchers found that some high-potency statins such as Lipitor, Zocor and Crestor have a greater likelihood to cause type-2 diabetes in patients. Other weaker statin drugs such as Pravachol were also observed in the study, along with non-statin drugs. The results showed that Lipitor has a 22% higher chance of causing type-2 diabetes in patients, particularly women.

Ironically, type-2 diabetes increases the chances of high blood pressure and heart attack — the very conditions that Lipitor is supposed to prevent, Lopez’s lawsuit states.

Lipitor (atorvastatin) is currently the best-selling drug in pharmaceutical history, and is manufactured by Pfizer. It continues to be one of the best-selling drugs in America, treating millions for their high cholesterol. Lipitor was originally approved by the FDA in December 1996, and is prescribed in oral ingestion tablets to be taken daily. Pfizer earns $7.9 billion annually from Lipitor sales.

The general results of the study were that statin drugs, whether high level or low-level potency, have a greater propensity for causing type-2 diabetes in patients. Lipitor and Zocor were found to cause type-2 diabetes in some patients regardless of the dose amount, while Crestor had to be taken in specific large doses and in close duration. 

Due to previous studies, the FDA required Pfizer to update Lipitor’s warning label in 2012 to include the risk of type-2 diabetes as a potential side effect of Lipitor. Previously, the warning labels for the medication failed to properly warn medical professionals and the general community about this possibility. 

This has caused a mass litigation movement against Pfizer, with hundreds people alleging negligence, false advertisement, concealment of information, and misrepresentation of a product. As of now, Health Canada and the FDA are reviewing additional investigations into Lipitor and diabetes.

Like other Lipitor diabetes victims, Lopez is seeking damages for medical compensation, negligence, and other punitive damages.

The Lipitor lawsuit is Ramona Lopez vs. Pfizer Inc., Case No.: 1:13-cv-00832-WJ-RHS, in the United States District Court of New Mexico, Santa Fe Division.

Obtain a Free a Lipitor Lawsuit Review

If you believe that you or a loved one has been the victim of Lipitor type-2 diabetes, you have legal options. Please visit the Lipitor Diabetes Class Action Lawsuit Investigation. There, you can submit your claim for a free legal review and if it qualifies for legal action, a seasoned Lipitor lawyer will contact you for a free, no-obligation consultation. You will be guided through the litigation process at no out-of-pocket expenses or hidden fees. The Lipitor diabetes lawyers working this investigation do not get paid until you do.